Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ligand Pharmaceuticals

    NASDAQ: LGND · Real-Time Price · USD
    150.89
    -2.90 (-1.89%)
    At close: Aug 15, 2025, 3:59 PM
    151.08
    0.13%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Ligand Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 167.13M 131.31M 196.25M 277.13M
    Cost of Revenue
    		 11.07M 35.05M 52.83M 62.18M
    Gross Profit
    		 156.06M 96.27M 143.42M 214.96M
    Operating Income
    		 -22.61M 11.94M -25.5M 78.89M
    Interest Income
    		 8.05M 7.71M 2.05M 886K
    Pretax Income
    		 2.52M 63.66M 36.01M 47.3M
    Net Income
    		 -4.03M 52.15M -5.22M 57.14M
    Selling & General & Admin
    		 78.65M 52.79M 70.06M 57.48M
    Research & Development
    		 21.43M 24.54M 36.08M 69.01M
    Other Expenses
    		 78.59M 7M 34.24M 9.57M
    Operating Expenses
    		 178.66M 84.32M 140.38M 136.06M
    Interest Expense
    		 3.04M 656K 1.8M 19.62M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 189.74M 119.37M 193.21M 198.24M
    Income Tax Expense
    		 6.55M 9.84M 41.23M -10.29M
    Shares Outstanding (Basic)
    		 18.29M 17.3M 16.87M 16.63M
    Shares Outstanding (Diluted)
    		 18.29M 17.76M 16.87M 17.25M
    EPS (Basic)
    		 -0.22 3.02 -0.31 3.44
    EPS (Diluted)
    		 -0.22 2.94 -0.31 3.31
    EBITDA
    		 40.79M 100.84M 54.41M 133.16M
    EBIT
    		 5.55M 64.32M 37.81M 91.82M
    Depreciation & Amortization
    		 35.24M 36.52M 43.39M 41.34M

    Add to Watchlist